Labviva
Labviva is an AI-native procurement platform specifically designed for the life sciences industry, offering a comprehensive purchasing platform, inventory management system, and dashboard analytics. It integrates with enterprise procurement systems to optimize spend, supplier networks, and purchasing channels, enabling life sciences companies to reduce R&D spend by an average of 20% in the first year and cut inventory stocking and sourcing costs by up to 41%. The platform provides transparency, competitive pricing, automated inventory control, compliance tracking, and rich data analytics, serving researchers, labs, purchasers, and suppliers globally. Labviva is recognized as a leader in AI-powered life sciences procurement and is expanding internationally with a strong leadership team and investor backing.
Labviva
Labviva is an AI-native procurement platform specifically designed for the life sciences industry, offering a comprehensive purchasing platform, inventory management system, and dashboard analytics. It integrates with enterprise procurement systems to optimize spend, supplier networks, and purchasing channels, enabling life sciences companies to reduce R&D spend by an average of 20% in the first year and cut inventory stocking and sourcing costs by up to 41%. The platform provides transparency, competitive pricing, automated inventory control, compliance tracking, and rich data analytics, serving researchers, labs, purchasers, and suppliers globally. Labviva is recognized as a leader in AI-powered life sciences procurement and is expanding internationally with a strong leadership team and investor backing.
TL;DR
What they do: AI-native procurement and inventory SaaS for life sciences
Founded / HQ: 2017; Boston, Massachusetts
Recent raise: Series B $25M (Jan 2025), total funding ≈ $55M
Claims: ~20% average R&D spend reduction in first year
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Laboratory procurement, inventory management, and supply-chain optimization for life sciences organizations.
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
25000000
Announced Jan 12–13, 2025; brought total funding to about $55M
Investor Signal
“53 Stations led Series B with participation from Biospring Partners, B Capital, and Glasswing Ventures”